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Abstract
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Background—The purpose of this study was to determine if dietary manipulation can reliably
induce early-stage atherosclerosis and clinically relevant changes in vascular function in an
established, well-characterized nonhuman primate model.
Methods—We fed 112 baboons a high cholesterol, high fat challenge diet for two years. We
assayed circulating biomarkers of cardiovascular disease (CVD) risk, at 0, 7, and 104 weeks into
the challenge; assessed arterial compliance noninvasively at 104 weeks; and measured
atherosclerotic lesions in three major arteries at necropsy.
Results—We observed evidence of atherosclerosis in all but one baboon fed the two-year
challenge diet. CVD risk biomarkers, the prevalence, size, and complexity of arterial lesions, plus
consequent arterial stiffness, were increased in comparison to dietary control animals.
Conclusions—Feeding baboons a high cholesterol, high fat diet for two years reliably induces
atherosclerosis, with risk factor profiles, arterial lesions, and changes in vascular function also
seen in humans.
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INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of mortality worldwide1–3, accounting
for nearly 50% of the deaths (Global status report on noncommunicable diseases 2010;
http://www.who.int/nmh/publications/ncd_report_full_en.pdf). CVD encompasses a broad
range of disorders of the cardiovascular system, including coronary heart disease,
cerebrovascular disease, and peripheral artery disease. The underlying cause of these
diseases is atherosclerosis - a complex disorder in which a host of different intrinsic and
extrinsic processes and factors contribute to the development of lesions that eventually
compromise normal vascular function4.
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Baboons (Papio hamadryas ssp.) have been used to great advantage in studies of biological
and environmental factors known to influence variation in risk for CVD in humans for over
60 years5. The baboon has been one of the more thoroughly genetically characterized
nonhuman primate species during the past 3 decades and, as such, the goals of a majority of
CVD-related studies utilizing baboons have been the detection, characterization, and
identification of genes6–8. However, in the “post genomics” era their value may be more
fully realized in experimental studies focused on mechanisms of development and
progression of atherosclerosis with clear and direct translational implications for its
diagnosis, prevention, and treatment. The baboon satisfies the majority of key criteria of an
ideal animal model for many studies of CVD and related disorders. The species mimics the
human subject developmentally, metabolically and pathophysiologically9–11; it is large
enough to allow repeated whole organism physiological and metabolic studies; it naturally
develops atherosclerosis and exhibits similar responses to an atherogenic diet, including
dyslipidemia and susceptibility to atherosclerosis. Also like humans, baboons exhibit
individual variation in the extent of atherosclerotic lesions and have been shown to develop
end-stage disease(s) comparable to those in humans9, 12, 13. Moreover, as in humans,
quantitative variation in traditional CVD risk factors is heritable in baboons5. Several studies
have confirmed and identified novel genes that play roles in the mediation of response to
atherogenic diets (e.g.,6, 8, 14–16). Further, baboon growth, development, maturation, and
aging follow a generalized Old World primate pattern17–20 shared with humans, and their
longer lifespans compared to small animal models provide unique opportunities to better
observe the development and progression of atherosclerosis, its comorbidities, and
consequent disease end-points. These characteristics correspond to those of the “ideal
animal model” for CVD-related studies – i.e., one likely to have potential for more
immediate translation to humans13.
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Many researchers eschew the baboon and related nonhuman primates in favor of smaller,
shorter-lived, less phenotypically and genetically variable animals like inbred mice, despite
well recognized dissimilarities of the latter to the human condition21. The most frequently
raised reasons for this are the greater time and expense associated with breeding and
developing atherosclerosis in a nonhuman primate like the baboon12, 13. These concerns
likely are amplified by a common misperception that genetic variability in non-inbred
baboon breeding colonies makes model development unpredictable, necessitating larger
initial sample sizes, which further increase total costs before data collection can even
begin21.
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In this paper, we demonstrate that the baboon is a reliable animal model for studies related
to onset, severity, and progression of atherosclerosis. We show that simple dietary
manipulation (i.e., addition of cholesterol and saturated fat) for two years induces the classic
features of early stage atherosclerosis – fatty streaks and fibrous plaques22 – as well as
increased stiffness in the large and medium arteries (decreased vascular compliance), a
hallmark of arteriosclerosis. Thus, a salient link between atherosclerosis and consequent
CVD can be produced predictably in a time frame that accommodates a majority of current
study designs. The data presented are derived from a recently completed phase of a longterm study of the interaction between diet and genes underlying variation in atherosclerosis
risk factors in baboons from a single, large, six-generation pedigree, the members of which
have been extensively characterized – genetically and phenotypically5.

MATERIALS AND METHODS
Author Manuscript

Humane Care Guidelines
All research procedures involving animals for this study were conducted in facilities
certified by the Association for Assessment and Accreditation of Laboratory Animal Care
(AAALAC) International at the Southwest National Primate Research Center (SNPRC) in
San Antonio, TX. All procedures were reviewed and approved by the Institutional Animal
Care and Use Committee at the Texas Biomedical Research Institute, the host institution for
the SNPRC.
Subjects and Diets
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The subjects of the study were 173 baboons [olive baboons (Papio hamadryas anubis),
yellow baboons (P. h. cynocephalus), and their hybrid descendants], all of which were
members of a large pedigreed breeding colony developed and maintained at the SNPRC.
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The study utilizes data from two groups of baboons distinguished by diet protocols. Baboons
in the control diet group were fed a basal diet, low in cholesterol and fat (LCLF), for at least
7 years prior to, and for the duration of, this study. Baboons in the experimental diet group
were fed the LCLF diet prior to beginning a two-year dietary challenge with a diet high in
cholesterol and saturated fat (HCHF). Data for animals in this group were obtained just prior
to beginning the two-year HCHF diet challenge (while on LCLF diet), at seven weeks, and
at the end of two-year period. Table 1 shows the composition of the basal (LCLF) diet and
the base diet used to prepare to atherogenic HCHF diet (respectively, “Monkey Diet 15%/
5LEO” and “Monkey Diet 25/50456,” LabDiet, St. Louis, MO). To make the HCHF diet, we
add a mix of lard, cholesterol, sodium chloride, vitamins [ascorbic acid and vitamin A (a
retinyl acetate)], and water to the base diet (Table 1). Our analyses of the resulting
atherogenic HCHF diet reveal the following23. Metabolizable energy is approximately 3.8
kcal/g; fats and carbohydrates each make up approximately 40% of calories, with proteins
comprising 20%. The composition of total fatty acids, determined by gas-liquid
chromatography of the fatty acid methyl esters [on DB-225 column (15 m), J&W Scientific],
is saturated fatty acids: myristic (1.7%), palmitic (24.9%), and stearic (17.9%);
monounsaturated fatty acids: palmitoleic (2%) and oleic (38.7%); and polyunsaturated acids:
linoleic (13.9%) and linolenic (0.9%). All baboons in the study were fed daily and allowed
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to eat ad libitum. The approximate mean per animal daily intake of the LCLF diet is 500 g
(~1500 kcal) and that for the HCHF diet is 400 g (~1200 kcal). Respectively, the mean
amount of cholesterol consumed daily by animals on each of these diets is approximately 30
mg and 2230 mg (the latter being equivalent to that in 10–12 large eggs).
Control diet groups—There were two control groups consisting of animals fed only the
LCLF basal diet for most of their lives, including two years prior to data collection. As the
control group for the arterial lesion study (see below), we selected 20 adult baboons: 9
females and 11 males (mean age = 12.6 years, range = 7.2 to 18.4 years). A second control
group, for the arterial compliance study, was made up of 41 animals: 11 females and 30
males (mean age: 11.7 years, range: 8.9 to 17.4 years).
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Experimental diet group—The experimental diet group included 112 baboons: 47
females and 65 males. Ages ranged from 8.1 years to 17.0 years. Mean age for the females
was 12.6 years (range = 8.7 to 17.0 years) and that of the males was 11.4 years (range = 8.1
to 14.1 years).
Arterial lesions
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We assessed lesion formation in three major arteries: the aortic arch, thoracic section of the
descending aorta, and the common iliac artery. Atherosclerosis in these three arteries has
been shown to be relevant to systemic risk of the disease and its complications in humans.
Aortic arch atherosclerosis is an independent risk factor for ischemic stroke and recurrent
vascular events24–26; atherosclerosis in the thoracic aorta is strongly predictive of
generalized atherosclerosis24 and coronary artery disease27, 28; and the common iliac arteries
are the second most frequently affected blood vessels (after the arteries of the thigh) in
atherosclerotic peripheral artery disease29. These associations have been replicated in earlier
studies of baboons from this same pedigreed breeding colony30, 31.
For the lesion studies, baboons in the control and experimental diet groups were humanely
euthanized and subjected to a standard necropsy procedure. Baboons in the experimental
group were euthanized after two-years on HCHF diet. The three above noted arteries were
defatted and dissected longitudinally. Adventitial surfaces were adhered to chip-board, and
the arteries were fixed in buffered 10% formalin and stained for 18 h with Sudan IV in 38%
isopropanol (v/v) made up as a stock solution and diluted to a consistent optical density (i.e.,
A520nm=0.22±0.01)32.
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A team of research support staff, trained by an experienced cardiovascular pathologist, first
identified fatty streaks and raised fibrous lesions (plaques) by visual inspection of the stained
arterial sections. The same team assessed all arteries from which data for this study were
obtained. Members of this team, trained by an experienced histomorphometrist, quantified
the extent of atherosclerotic lesions (i.e., percent area covered by fatty streaks, plaques, or
both when each was present) on arterial surfaces using BioQuant Image Analysis software
(Nashville, TN) as previously described33). Briefly, an entire artery was photographed and
images imported into the BioQuant software. Subsequently, regions in the imager
corresponding to lesion were scanned to obtain the fraction of pixels in affected regions
compared to the entire artery template. The fraction of involved pixels represented the
J Med Primatol. Author manuscript; available in PMC 2019 February 01.
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percent of intimal surface area or the extent of a specific type of lesion in a given artery as
explained33. Age- and sex-adjusted residuals of these measures were normalized (inverse
Gaussian transformation).
Arterial compliance
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We used a computerized central blood pressure and pulse wave analysis/pulse wave velocity
(PWA/PWV) assessment system (AtCor Medical, Itasca, IL) to noninvasively assess
parameters related to arterial compliance (stiffness) in two cohorts of baboons: 50 animals
fed the HCHF atherogenic challenge diet for two years and 41 fed the LCLF basal diet for
two years. Following the validated approach of Lazar et al34 with bonnet macaques (Macaca
radiata), the chosen peripheral artery was brachial and all assessments were done on the left
side. We conducted evaluations in animals immobilized with an intramuscular injection of
ketamine hydrochloride (10 mg/kg) after observing a stable state – i.e., stable pulse rate and
resting blood pressures within one standard deviation of values observed in previous studies
of non-anesthetized (tethered) baboons from this same pedigreed colony35. Note: Ketamine
HCl has been shown to be “a suitable anesthetic for endocrine, metabolic, and
cardiovascular studies,” including vascular compliance in baboons36, 37, 34 and other Old
World Monkeys38 because it generally does not significantly affect vascular resistance or
systemic blood pressure39. We accepted data for analyses only if the operators observed
consistent, acceptable waveform profiles for at least ten seconds. Acceptable waveforms
were those with in-device quality indexes (a function of mean pulse height, variation in
pulse height and diastolic pressure, and the maximum rise of the peripheral waveform)
greater than 80%. All assessments were performed by research staff after training by both
the device manufacturer and a veterinary researcher with experience using the device with
nonhuman primates.
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CVD-related biomarkers
We also obtained data on circulating CVD risk factors, including lipids and lipoproteins,
lipoprotein-related enzymes, and biomarkers of inflammation and oxidative stress from
fasting blood samples collected at three time points from all animals undergoing the twoyear dietary challenge and at one-time point from animals in the basal LCLF diet control
group for lesion studies.
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Lipids and Lipoproteins—We quantified the concentrations of the following serum
lipids and lipoproteins. Total serum cholesterol (TSC) and triglyceride (TG) concentrations
were determined enzymatically using commercial reagents in a clinical chemistry analyzer.
High density lipoprotein cholesterol (HDLC) was measured in the supernatant after heparinMn+2 precipitation, and non-HDLC (V+LDLC) was calculated as the difference between
total and HDLC. Concentrations of apolipoproteins AI (APOAI), B (APOB), and E (APOE)
were determined using an immunoturbidometric approach with commercial reagents in a
clinical chemistry analyzer. We provide detailed descriptions of the methods used in these
assays elsewhere6, 40, 41.
We used composite gradient gels to further resolve LDLs and HDLs on the basis of size37
and Sudan black B to quantify lipoprotein cholesterol size distributions. Fractional
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cholesterol absorbance among APOB-containing lipoproteins was estimated for the
following very low density lipoprotein (VLDL) fractions and LDL fractions: VLDL1C (36–
33 nm), VLDL2C (33–30 nm), LDL1C (30–28 nm), LDL2C (28–27 nm), LDL3 (27–26
nm), and LDL4 (26–24 nm): and HDL fractions: HDL1AC (24–20 nm), HDL1BC (20–13
nm), HDL2C (13–9.9 nm), and HDL3C (9.9–8.2 nm). From these we estimated serum
concentration for each fraction by multiplication with non-HDL or HDL cholesterol
concentrations as appropriate. For cholesterol distributions only, we estimated median
diameters for APOB-containing lipoproteins (Bmed; 24–36 nm) and HDLs (Hmed; 8.2–24
nm), which were defined as the diameter where half the absorbance was on larger, and half
was on smaller, particles. We measured plasma oxidized LDL (OxLDL) concentrations
(U/L) immunologically using a sandwich-style enzyme-linked immunoabsorbent assay
(Mercodia Oxidized LDL ELISA; ALPCO Diagnostics, Salem, NH)41.
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Lipoprotein-related enzymes—We measured serum activity levels of two lipoproteinassociated enzymes, lipoprotein-associated phospholipase A2 (Lp-PLA2) and paraoxonase 1
(PON1) on two substrates. We determined the activity of the APOB associated enzyme, LpPLA2 (µmol/min/L), using 2-thio-PAF as substrate in a commercial microplate-based
colorimetric assay42). We used a microplate-based colorimetric assay43 to measure the
activity (µmol/min/L) of HDL-associated enzyme, PON1, with paraoxon as substrate
(PON1-para) in one case and arylesterase with phenylacetate as substrate (PON1-aryl) in the
other.
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Inflammation and Oxidative Stress—We assayed interleukin-8 (IL8; pg/mL) using a
sandwich-style enzyme-linked immunoassay kit, as suggested by the manufacturer (R&D
Systems, Inc.)44. Total antioxidant status (TAS), reflecting the overall antioxidant capacity
of serum, was defined as the ability to prevent oxidation of 2,2'-azino-di-(3ethylbenzthiazoline sulfonate) by metmyoglobin with the use of a kit from Calbiochem (San
Diego, CA)41. We used a high-sensitivity assay kit (Kamiya Biomedical, Seattle), with a
latex particle-enhanced immunoturbidometric method, to measure C-reactive protein (CRP)
concentrations (mg/L). We quantified the Von Willebrand factor (vWF; expressed as
percentage of an international standard value41) using a sandwich-style enzyme-linked
immunoassay kit (Diagnostica Stago, Parsippany, NJ).
Data analysis

Author Manuscript

Summaries of raw data are presented as means, standard deviations, and medians. Unless
otherwise indicated, data in all analyses were i-normalized residuals of the quantitative
variables after adjustments for the significant mean effects of common covariates like sex,
age, body weight, etc. Because the data are derived from related animals (mean kinship
coefficient = 0.03, between second and first cousins), we used a maximum likelihood-based
variance decomposition approach, implemented in SOLAR46, that is designed to account for
kinship in data from pedigrees to estimate both the mean effects of covariates and
appropriately weighted correlations. We used likelihood ratio tests to assess significance of
these parameter estimates.
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We used a Bayesian model selection approach, also implemented in SOLAR, to identify the
subset of the highly inter-correlated CVD risk factors contributing the most independent
information to lesion extent. Using this method, we computed an approximate Bayes factor,
the Bayesian Information Criterion (BIC), for each covariate model47. BIC differences
greater than 2 provide positive evidence of support for one model over another (posterior
probabilities, PPosterior, ≥ 75%); differences of 6 units indicate stronger support (PPosterior, =
95%); and differences greater than 10 units indicate posterior probabilities of at least 99%.
The approach automatically eliminates multiple testing bias and the penalties for it47, 48.

Author Manuscript

In all tests, α = 0.05. When necessary to control for multiple testing bias in non-Bayesian
analyses, we used Bonferroni adjusted p-values; even though they are overly conservative,
given expected intercorrelations among the CVD risk factors. For descriptive analyses in
which kinship was not an issue, we used statistical routines implemented in the
commercially available software package NCSS, version 07.1.949.

RESULTS
Arterial lesions
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We observe atherosclerotic lesions (fatty streaks and/or plaques) in the aortic arch, thoracic
aorta, and common iliac artery (Figure 1). Lesions are observed in at least one artery from
111 of 112 animals (99%) that completed the two-year diet challenge; more than twice the
40% prevalence observed in the same three arteries harvested from 20 dietary control
animals. All three arteries are affected in 109 baboons (Table 2). The mean percentages of
the areas covered by lesions (fatty streaks plus plaques, when the latter are present) in all
three arteries from the challenge diet group are approximately 2.6 times to 5.0 times larger
than in those from controls (P<0.0004). Two-sample t-tests show no difference between the
percentages of areas covered by lesions in the aortic arch and common iliac artery (*P =
0.694) but the means for each of these arteries differ significantly from that of the thoracic
aorta (*P = 0.0002).
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Extent of atherosclerotic lesions for the aortic arch and thoracic aorta, but not the common
iliac artery, differ by sex. Mean percentages for areas affected in females are significantly
greater than that in males in both the aortic arch (P = 0.00052) and the thoracic aorta (P =
0.000009), but not in the common iliac artery (P = 0.768). These analyses also reveal a
significant effect of age on lesion extent in the aortic arch (P = 0.0023) and common iliac
artery (P = 0.039), but not in the thoracic aorta (P = 0.42), even when accounting for the
possible confounding effect of variation in days on the challenge diet which does exert a
significant mean effect on percent area covered by fatty streaks in the thoracic aorta (P =
0.032).
The percentages of the areas in the three arteries covered by atherosclerotic lesions are
significantly inter-correlated (P < 0.001). The correlations between their extent at the aortic
arch and each of the other two sites (i.e., thoracic aorta: r = 0.488, r2 = 0.238; common iliac
artery: r = 0.541, r2 = 0.293) are greater than that between the thoracic aorta and the
common iliac artery (r = 0.317, r2 = 0.100).
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We observe plaques in only 29 baboons (12 females and 17 males) that completed the
HCHF diet challenge, but in only four (20%) dietary control animals. The number of plaques
per challenge diet baboon range from one to seven, versus one to four for the eight affected
control diet animals.
While we observe no plaques in the thoracic aorta, three individuals (two females, one male)
have plaques in the aortic arch and 26 (10 females, 16 males) have plaques in the common
iliac artery. On average, plaques in the aortic arch are smaller than those in the common iliac
artery (covering 0.2% to 1.0% vs. 0.6% to 6.1% of the intima, respectively).
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Atherosclerotic lesion extent is only moderately predictive of the presence and numbers of
plaques in the 112 animals that completed the two-year dietary challenge (χ2[3] = 7.96, P =
0.047) and nominally correlated with plaque size in the common iliac artery (r = 0.353, r2 =
0.125, P = 0.042).
Circulating biomarkers of CVD risk—Concentrations (or activities) of the majority of
circulating biomarkers of lipid/lipoprotein metabolism and inflammation show significant
mean changes in the animals fed the HCHF challenge diet for two years (Figures 2A–2J).
Values for HDL3C, LDL3C, vWF, and TAS at two-years (Week 104) are not significantly
different from those at baseline (Week 0). An interesting observation is that all variables,
except IL8 and TAS, exhibited a significant increase in the first seven weeks of the HCHF
diet challenge; with the values for the major lipoprotein cholesterol classes, OxLDL,
LpPLA2, PON-aryl, IL8, and vWF being greater than those after two years.
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Concentrations of TSC and other biomarkers within or associated with the β-lipoprotein size
range consistently show the strongest correlations with extent of lesions in the three arteries,
as well as with PC1, the first principal component accounting for approximately 70% of the
covariance among lesion sizes in all 3 arteries (Tables 3A–3C). Significant correlations are
most pronounced for the aortic arch and common iliac artery. Taking into consideration only
these significant correlations, the percent of the variance (r2 × 100) shared by the extent of
lesions with TSC and key β-lipoprotein traits ranges from 9% to 20%. Compared to those
measured at baseline, more CVD biomarkers assayed at either time point (seven weeks or
two years) during the dietary challenge are significantly correlated with the extent of lesions
in the three arteries. The number and means of correlations that are significant after
Bonferroni corrections are greatest for those based on data from samples collected at seven
weeks.
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Bayesian model selection analyses of the subset of biomarkers exhibiting at least nominally
significant correlations with the extent of lesions in any artery support the correlation
analysis results and identify LDL1C (i.e., large LDL particles between 28 and 30 nm in
diameter), measured at seven weeks on the HCHF diet, as the single best predictor of
variation in PC1. The model with the closest BIC value is the two-degree model that
includes LDL1C measured at both seven weeks and 104 weeks (BICdegree 1 = −25.11,
BICdegree 2 = −23.09, difference = 2.02, PPosterior = 0.75). Positive evidence of support for
these two models over the model with the next highest BIC, a three-degree model including
LDL1C at seven and 104 weeks and LDL3C at 104 weeks, respectively, is approximately
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85% and 79%. All more saturated models have much larger BIC values (weaker evidence),
indicating that no additional information is to be had by addition of any number of the other
covariates (previously found to be correlated with PC1) to a model that only included
LDL1C at seven weeks.
An incidental, but still interesting, observation is suggestive evidence (P = 0.07) that some of
the variation in the extent of lesions, as represented by PC1, is attributable to the additive
effects of genes. Although, as we indicated in the Materials and Methods section, the mean
kinship is low, there is sufficient variability in degrees of relationship among all possible
pairs of baboons in these 112 to detect some evidence of genetic effects on the trait. The
estimated heritability (h2), or the proportion of the residual phenotypic variance in PC1 that
is due the effects of genes, in the model with the lowest BIC (above) is h2 = 0.21 ± 0.12.
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After Bonferroni correction, OxLDL concentration and the median diameter of HDL
particles are significantly correlated with the sum of plaque extent (P < 0.0018) in all three
arteries (respectively, r = 0.603, r2 = 0.364 and r = −0.575, r2 = 0.331). We find nominal
evidence (i.e., P < 0.05) for correlations between plaque extent and several additional
variables related to LDL (APOB, r = 0.449, r2 = 0.201 and the APOB associated LpPLA2, r
= 0.368, r2 = 0.135) and HDL (total HDLC, r = −0441, r2 = 0.194; HDL1BC, r = −0.475, r2
= 0.226; and PON-aryl, r = 0.495, r2 = 0.245).
Arterial Compliance (Stiffness)

Author Manuscript

Data on arterial compliance and blood pressures come from 50 animals sampled randomly
from the 109 in which lesions of some size are seen in all three arteries after being fed the
HCHF diet for two years and from 41 adult baboons fed the LCHF diet for two years (Table
4). The two groups do not differ significantly by age (p=0.39) or body weight (p=0.15), even
when sex-adjusted residuals are analyzed (results not shown).
All measures from the pulse wave analyses show higher values in challenge-diet animals
than in controls, but we find only nominally significant evidence of increased arterial
stiffness (decreased arterial compliance) in analyses of PWV, augmentation index (Aix), and
related measures: augmentation pressure (AugP) and aortic pulse pressure (APP), and aortic
systolic pressure (ASP). In diet-challenged animals, mean PWV and mean AIx, respectively,
are 23% (P = 0.0184) and 58% (P = 0.0073) greater than in control animals. Similarly, mean
AugP and APP in animals fed the HCHF diet for two years, respectively, are 78% (P =
0.0019) and 14% (P = 0.0199) greater than in control group baboons.
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PWV is significantly correlated with percent artery area covered by plaque (r = 0.365, r2 =
0.133) and fatty streaks in the thoracic aorta (r = 0.368, r2 = 0.135) after correction for
multiple testing (Table 5). Evidence for correlation between AIx and extent of fatty streaks
in the thoracic aorta is suggestive (r = 0.309, r2 = 0.095). AugP shows similar, suggestive
correlations with fatty streak extent in the thoracic aorta (r = 0.282, r2 = 0.080); and with
total number of plaques (r = 0.285, r2 = 0.081).
We observe the strongest and most consistent correlations (significant after adjustment for
multiple testing) between arterial pressures and lesion extent variables. Brachial and aortic
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diastolic pressures are significantly correlated with extent of plaques, number of plaques,
and the summary measure of lesion extent (PC1). These correlations range from r = 0.388
(r2 = 0.151) to r = 0.580 (r2 = 0.336). Mean brachial artery and aortic systolic pressures also
show high correlations with PC1 (r = 0.431, r2 = 0.186 and r = 0.396, r2 = 0.157,
respectively) and fatty streak size in aortic arch (r=0.59, r2 = 0.348 and r =0.426, r2 = 0.181,
respectively).

DISCUSSION
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Ultimately, successful treatment and/or prevention of atherosclerosis will require an
understanding of mechanisms by which interactions between CVD risk factors and the cells
of the vascular endothelium result in the development and progression of arterial lesions
from simple fatty streaks to unstable plaques. Although recent advances in clinical
diagnostic and research technologies (e.g., imaging modalities) have made it possible to
detect and determine the extent of atherosclerosis in human research participants and
patients with greater precision than ever before, many critical studies of disease onset and
progression, and responses to therapy remain impractical, if not impossible, in humans. It is
for this reason that we turn to animal models to elucidate pathogenetic steps and causalities
in atherosclerosis50.
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Our study shows that the baboon is a suitable model for human atherosclerosis studies in
that the disease can be reliably induced in a time frame which will facilitate rapid research
progress from discovery to translational outcomes in our own species. Together, the range of
inter-individual phenotypic variation in the extent of lesions and their association with
biomarkers of CVD risk and pathophysiology observed in nearly 100% of the baboons
studied correspond well with what is observed in the early stages of atherosclerosis in
humans22, 33. All lesions observed following a two-year exposure to the atherogenic diet,
including those underlying raised areas, include fatty streaks. These fatty streaks, observed
and described in reports of studies conducted over the past 35 years with baboons from
earlier generations of this same pedigreed breeding colony (e.g.,31), correspond to AHA
Type II lesions51, from which more complicated plaques arise. As other studies of
biomaterials and data from these same baboons have shown, reliable, consistent production
of sizable and widespread early stage lesions in two years makes the baboon a most
appropriate model for studies designed to dissect and understand the biological mechanisms
responsible for the earliest disruptions of vascular cellular function leading to
atherosclerosis52, 53. Such studies can realistically be expected to further inform efforts to
develop and evaluate interventions and individually tailored lifestyle recommendations to
prevent early stage lesion formation.

Author Manuscript

In earlier studies of baboons from this breeding colony, raised lesions have been shown to be
relatively uncomplicated fibrous plaques, made up primarily of vascular smooth muscle cells
and connective tissue with varying amounts of lipid, most resembling AHA lesion Types Va
or Vc30, 31, 51, 54. Our observation of these plaques in approximately 28% of the affected
animals indicates that, under the described experimental conditions, pathology consistent
with the progression of atherosclerosis can be induced in baboon as well.
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Our observations not only reinforce the validity of baboon model for studies relevant to our
own species but they also point to the utility of baboons for studies involving experimental
manipulation and/or control, which may be impractical in humans, designed to assess
genetic influences on development, severity, and progression of atherosclerosis, as well as
responsiveness of the disease to therapeutic interventions.

Author Manuscript

As reported for this species in the past9, 31, prolonged exposure to the HCHF diet
significantly increased both prevalence and extent of atherosclerotic lesions. However, our
observation of lesions in 40% of the dietary control group confirms that baboons, like
humans but unlike mice, can naturally develop lesions without genetic manipulation. This is
consistent with the results of previous studies, which have found that free-living baboons
and captive baboons fed the LCLF diet also develop arterial lesions resembling those
naturally observed in humans55, 56 and further reinforces the validity of the baboon model of
atherosclerosis for translational studies.

Author Manuscript

To a large degree, our observations of responses of “classical” CVD risk factors – i.e.,
circulating concentrations and/or activities of biomarkers of lipid and cholesterol
metabolism – to the HCHF challenge diet reaffirm the relevance of the baboon for studies of
CVD risk factors in humans. In addition to observing evidence of expected lipemic
responses to the diet, the concentrations of these biomarkers, particularly those within the
LDL and VLDL particle size ranges, are the best predictors of overall extent of lesion
development in baboons, corresponding well to their known pro-atherogenic effects in
humans. Evidence of expected anti-atherogenic effects of molecules within the HDLC
particle size ranges, albeit weaker, is equally suggestive of the baboon-human
correspondence. Similarly, observed positive and negative correlations of extent of plaques
with biomarkers related to, respectively, LDL (e.g., oxidized LDLC, APOB, LpPLA2) and
HDL (e.g., HDLmed, total HDLC, HDL1BC, and PON-aryl) are consistent with well
documented associations observed in human CVD epidemiology,22, 31.

Author Manuscript

Results from our analyses of these “classical” risk factors may point also to areas for further
study in baboons, particularly with respect to the duration of exposure to a HCHF diet
necessary to induce atherogenesis. For example, concentrations of circulating biomarkers of
lipid and lipoprotein metabolism measured at seven weeks and two years into the HCHF diet
challenge are both elevated significantly compared to those at baseline. However, the 7-week
values are both greater than those measured at the end of the challenge and equally or more
predictive of lesion extent at the end of the study (approximately 22 months later). The
pattern of correlations between biomarkers and the extent of raised plaques is consistent
with these findings – i.e., measures at seven weeks into the atherogenic diet challenge are
more highly correlated with plaque development than those at either baseline or at the end of
the 2-year challenge. These observations, plus others from shorter term studies57, suggest
that circulating biomarkers obtained as early as seven weeks post diet challenge are
predictive of future atherosclerosis burden. Also, as the concentrations of circulating risk
factors like LDLC either peak or plateau at or before seven weeks, the model likely would
be valuable for further studies of genetic and environmental (intrinsic and extrinsic) factors
that influence variation in the norms of reaction for lipid and cholesterol homeostasis in the
continued presence of dietary stressors. Previous studies in the larger pedigreed baboon
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breeding colony from which these animals were selected have provided evidence for shared
(pleiotropic) genetic effects, as well as diet-specific genetic effects on many of these
circulating atherosclerosis risk factors in the two dietary environments studied here58–60.

Author Manuscript

Although not previously investigated in baboons, our PWV/PWA results comport with those
from a series of studies conducted more than two decades ago with two other Old World
Monkey species, cynomolgus macaques (Macaca fascicularis) and rhesus macaques
(Macaca mulatta). Limited in sample size, those studies variously found evidence for altered
aortic distensibility, elasticity, and composition, increased arterial stiffness, and altered
central blood pressures in macaques fed diets high in cholesterol and fat for 26 to 36 months,
as well as some evidence for association with extent of atherosclerotic lesions in both
progression and regression61–65. Specific observations relevant to this study include an
inverse correlation with peak compliance in 12 monkeys fed a high cholesterol diet for 26
months65 and increased arterial stiffness in small groups of monkeys fed an HCHF diet
(40% of calories from butter) for up to 30 months47.
More important, results from the current study with pedigreed baboons are concordant with
associations of decreased arterial compliance with atherogenic diets, atherosclerosis risk
factors, the disease itself, and CVD outcomes in general in a sizeable number of crosssectional and mixed longitudinal epidemiological studies in humans, and in smaller casecontrol studies and randomized trials as well66–72). The degree of correspondence between
observations on arterial stiffness (arteriosclerosis) in this study and those in humans strongly
supports the value of the pedigreed baboon as a model for research on the effects of longterm exposures to diet and other disease risk factors on atherosclerosis and its vascular
consequences, which underlie variation in risk, severity, and progression of CVD.

Author Manuscript

While the pedigreed baboon model for early stage atherosclerosis certainly could be
exploited for an analog of a human CVD epidemiological study (e.g., to mimic the effects of
an average diet on the cardiovascular health of a human population), that is not our objective
here. For our purposes, the principal value of the model derives from our ability to use diet
as a tool to reliably and quickly induce atherosclerotic lesions on which we can conduct
studies of the molecular and cellular determinants of variation in their initiation,
development, severity, and progression; all in a species exhibiting greater genetic, anatomic,
and physiological proximity to our own than most other animal models.

Author Manuscript

It is true that the relative amounts of cholesterol and fats in the HCHF atherogenic diet
exceed those consumed on a daily basis by the average person in the US73. This diet has
been designed to overcome the effects genes on inter-individual variation in susceptibility to
endothelial damage and it does: increasing the probability of atherogenesis to nearly 100%
in our studies.
Elevated though they are, the amounts of fat and cholesterol in the HCHF atherogenic diet
are not so extreme as to compromise the relevance of the model to the human condition.
Recent estimates place the mean fat intake for US men and women at approximately 33% of
daily calories73, just above the recommended upper limit of 30% in the Dietary Guidelines
for Americans74. With 40% of total calories due to fat, the HCHF diet fed to the baboons
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certainly would be considered an unhealthy one, but not so extreme as those used in some
short-term diet studies with human participants (e.g., 55%75 and 73%76). The HCHF diet
also corresponds well to high fat diets, deriving 35% to 40% of calories from fats, used
recently by others in cardiometabolic disease-related studies with related nonhuman primate
species77–79; as well as widely-used experimental diets formulated by several companies to
model atherogenic “Western” diets: e.g., 42% (Teklad TD88137, Harlan Laboratories, Inc.,
Indianapolis, IN) and 40% (TestDiet 5342, LabDiet, St. Louis, MO).
Likewise, at approximately 17.6% of total calories, the percentage of calories attributable to
saturated fats in our HCHF diet is 33%–40% higher than the 11% recommended in the
Dietary Guidelines for Americans74; with the percentage due to the highly atherogenic 16:0
palmitic acid exceeding the estimated mean daily intake by Americans at all ages73: i.e.,
about 10% versus 6.2%, respectively.

Author Manuscript

Relative to that consumed on a daily basis by the average American, the amount of
cholesterol in the HCHF atherogenic diet also is very high. As indicated in our description
of the diet (Materials and Methods), the average amount consumed daily by each baboon
was equivalent to that found in ten to twelve large eggs. However, compared to humans,
many nonhuman primate species exhibit substantial variability in their responses to dietary
cholesterol80. Consequently, investigators working with several species have used very high
dietary cholesterol relative to standard American diets (from 0.5 – 2 mg/kcal or 1250 – 5000
mg/2500 kcal) to enhance the effects of dietary fats and accelerate atherogenesis.

Author Manuscript

Because we repeatedly have shown that inter-individual variation in most “traditional” CVD
risk factors – and now, likely lesion extent – has a heritable component, the considerable
variation we observe in lesion development in both experimental and control baboons is a
desirable characteristic, rather than a conundrum as some may describe it21. Indeed, it makes
a pedigreed breeding colony of baboons, such as those from which these animals are
derived, valuable for a broader range of studies than any single inbred line of most smaller
mammalian species. Knowledge of pedigree relationships can be exploited to identify and
select animals based on degrees of both phenotypic and relevant genetic similarity (even
prior to, or without, molecular genetic characterization) for case-control type study designs
(for example). It also allows for production of offspring that are phenotypically and
genetically similar for study. Further, it makes possible larger-scale, pedigree-based studies
with sufficient statistical power for detecting the effects of individual genes, gene-byenvironment (e.g., diet, pharmaceutical agent) interactions, and more. All these approaches
have benefited CVD research projects with baboons from this pedigreed
colony35, 57, 60, 81, 82.
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CONCLUSIONS
Based on our results, we conclude that a diet high in cholesterol and fat can be employed to
reliably produce a baboon model of human atherosclerosis that has greater translational
potential than other frequently used species. This potential is attributable to the fact that the
development of atherosclerotic lesions and their functional consequences (e.g., decreased
arterial compliance), as well as interrelationships among “classical” CVD risk factors,
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closely mirror those in humans. In addition, our study shows that baboons exhibit variation
in extent of lesions as seen in humans. The potential for translation is further enhanced by
the phylogenetic proximity of baboons to humans, which results in a high degree of genetic,
anatomic, and physiological correspondence between the two species.

Author Manuscript

Given that the HCHF diet alone can induce a disease state in nearly 100% of adult baboons
in two years or less, the baboon is a practical model for research into the pathobiology of
atherosclerosis and its consequences for CVD and comorbidities. Considering the time
frames associated with most independent investigator-initiated, NIH-funded research
projects, this relatively brief interval allows for development and study of the disease state
within a single funding cycle. The interval could be shortened further, thus facilitating more
rapid progress towards research objectives using the baboon model, by augmenting the
HCHF diet with other atherogenic components – e.g., simple carbohydrates83, 84.
Additionally, dietary manipulation could be used to establish a standing nonhuman primate
CVD research resource comprising adult baboons in which atherogenesis is nearly certain to
have been initiated and progressed to a stage in which changes in vascular endothelial
function (for example) are observable at the beginning of any project. An NIH-sponsored
National Primate Research Center, like the SNPRC, would be well situated to develop and
maintain such a resource.
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Figure 1.
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Atherosclerotic lesions in three arteries from baboons after being stained with lipophilic
Sudan IV. Columns: Common iliac artery (Left), thoracic aorta (center), and aortic arch
(right). Rows 1 and 2: Control diet animals with no (row 1) and highest (row 2) total percent
area affected. Experimental diet animals with lowest (row 3) and highest (row 4) percent
total area affected.
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Fig. 2.
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A–2J. Serum biomarkers of lipid/lipoprotein metabolism, inflammation, and oxidative stress
measured at three time-points in 112 baboons in the two-year HCHF diet challenge study: at
baseline (Week 0, LCLF diet), seven weeks into the HCHF diet challenge (Week 7), and at
the end of the HCHF dietary challenge (Week 104). Figure 2A, concentrations of major
lipoproteins, apolipoproteins, and triglycerides; Figure 2B. concentrations of HDLC
fractions; Figure 2C, concentrations of V+LDLC fractions; Figure 2D, Hmed and Bmed;
Figure 2E, concentration of OxLDL; Figure 2F, activity of lipoprotein associated enzymes,
LpPLA2, PON-para, and PON-aryl; Figure 2G, concentrations of CRP; Figure 2H,
concentrations of IL8; Figure 2I, vWF as percentage of international standard value; and
Figure 2J, TAS.
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Table 1
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Characteristics of the LCLF Diet and HCHF Base Diet
LCLF

HCHF base
diet

Carbohydrate, % kcal*

67.3

63.5

Protein, % kcal*

19

31.5

Fat, % kcal*

13.7

5.0

0.02

0.0

Energy, kcal/g provided by

Cholesterol, mg/kcal
Nutrients, % of ration

15.5

25.7

Arginine, %

0.85

1.40

Cystine, %

0.23

0.37

Glycine, %

0.63

1.05

Histidine, %

0.41

0.62

Isoleucine, %

0.65

1.27

Leucine, %

1.33

2.48

Lysine, %

0.74

1.22

Methionine, %

0.32

0.48

Phenylalanine, %

0.77

1.31

Tyrosine, %

0.53

0.93

Threonine, %

0.56

0.96

Tryptophan, %

0.19

0.31

Valine, %

0.83

1.31

Serine, %

0.80

1.42

Aspartic acid, %

1.46

2.56

Glutamic acid, %

3.71

6.22

Alanine, %

0.890

1.49

Proline, %

1.37

2.18

Taurine, %

0.00

0.01

Primary fat source

Vegetable

Vegetable

Cholesterol, ppm

49

0.0

Fat (ether extract), %

5.0

1.8

Fat (acid hydrolysis), %

6.2

3.1

Total saturated fatty acids, %

1.17

0.5

Total monounsaturated fatty acids

1.33

0.5

C18:2 linoleic

2.1

1.3

C18:3 linolenic

1.9

0.1

Other omega-3 polyunsaturated fatty acids

0.23

0.1

8.3

4.7

22.7

17.1

Protein, %

Author Manuscript
Author Manuscript

Fatty acid composition, %†

Author Manuscript

Fiber (crude), %
Neutral detergent fiber, %
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LCLF

HCHF base
diet

10.2

6.8

54.7

51.8

Starch, %

28.5

32.2

Glucose, %

0.25

0.1

Fructose, %

0.27

0.1

Sucrose, %

1.73

2.6

Lactose, %

0.15

1.7

76

75.3

Gross energy, kcal/g

3.84

3.97

Physiological fuel value, kcal/g

3.25

3.26

Metabolizable energy, kcal/g

3.01

3.01

Ash, %

6.1

5.8

Calcium, %

1.00

1.03

Phosphorus, %

0.70

0.60

Phosphorus (non-phytate), %

0.40

0.24

Potassium, %

0.80

0.98

Magnesium, %

0.21

0.23

Sulfur, %

0.21

0.28

Sodium, %

0.35

0.10

Choline, %

0.55

0.11

Fluorine, %

24.3

5.12

Iron, ppm

378

387

Zinc, ppm

131

162

Manganese, ppm

118

145

Copper, ppm

37

22

Cobalt, ppm

0.76

0.53

Iodine, ppm

1.54

1.75

Chromium, ppm

1.79

0.42

Selenium, ppm

0.37

0.48

Carotene, ppm

1.1

1

Vitamin K (as menadione), ppm

3.2

3.0

Thiamin hydrochloride, ppm

11.0

17.0

Riboflavin, ppm

12.0

8.9

Niacin, ppm

123

113

Pantothenic acid, ppm

61

62

Choline chloride, ppm

1200

1800

Folic acid, ppm

2.2

10.8

Pyridoxine, ppm

15.0

14.75

Biotin, ppm

0.2

0.2

Acid detergent fiber, %
“Nitrogen-Free Extract” (by difference), %

Total digestible nutrients, %

Minerals
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Author Manuscript

Vitamins

Author Manuscript

J Med Primatol. Author manuscript; available in PMC 2019 February 01.

Mahaney et al.

Page 25

Author Manuscript

LCLF

HCHF base
diet

Vitamin B-12, mcg/kg

33

48

Vitamin A, IU/g

40

43

Vitamin D-3 (added), IU/g

7.0

7

Vitamin E, IU/kg

49

110

Ascorbic acid, ppm

541

500

*

Based on specifications of the manufacturer, Ralston Purina Co.
“Monkey Diet 15%”/5LEO, Ralston Purina Company/LabDiet
“Monkey Diet 25”/50456, Ralston Purina Company/LabDiet

†

Fatty acid composition of the diets was determined by using gas-liquid chromatography of the fatty acid methyl esters on a DB-225 column (15

m) (J&W Scientific) with temperature programming from 100°C to 200°C at 3.25 °C/min.23
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29

3.1 (1.8)

14.2 (17.2)
0.4

0.2

-

0.3

0.2

0.3

min

6.1

77.5

-

73.1

1.1

55.5

max

4

6

0

4

0

4

n

3.6 (2.8)

5.4 (2.6)

-

8.7 (3.2)

-

2.7 (3.0)

x̄ (SD)

0.4

0.9

-

4.09

-

0.2

min

LCLF Diet
Controls (n=20)

7.3

8.0

-

11.2

-

7.0

max

ns

<0.0001

-

<0.0001

-

0.0004

P1

P values derived from comparison between extent of fatty streaks in two-year diet challenged group and control group by means of two-sample t-tests.

1

HCHF, high cholesterol, high fat atherogenic challenge diet; LCLF, low cholesterol, low fat baseline diet; n, number of individuals with affected artery; x̄ (SD), mean and (standard deviation); min,
minimum observed value; max, maximum observed value.

109

-

0

Plaque %

24.7 (17.6)

Lesion %

Common iliac

Plaque %

Lesion %

0.6 (0.4)

13.6 (11.0)

x̄ (SD)

110

3

Thoracic aorta

110

Plaque %

n

Lesion %

Aortic arch

Artery/Trait

HCHF Diet
104 Weeks (n=112)

Total extent of atherosclerotic lesions and plaque extent (percent of artery area covered) in three arteries in 112 baboons fed HCHF diet and 20 Control
baboons fed a baseline LCLF diet for two years.

Author Manuscript

Table 2
Mahaney et al.
Page 26

J Med Primatol. Author manuscript; available in PMC 2019 February 01.

Mahaney et al.

Page 27

Table 3

Author Manuscript

Correlation1 between extent of atherosclerotic lesions and serum biomarkers of lipid/lipoprotein metabolism
and inflammation in 112 pedigreed baboons at three time-points before and during HCHF atherogenic diet
challenge.
A. Baseline (week 0, LCLF diet) prior to the two-year HCHF atherogenic diet challenge study.

Author Manuscript
Author Manuscript

Trait

PC1

Aortic Arch

Thoracic Aorta

Common Iliac

TSC

0.309**

0.230*

0.205*

0.315**

HDLC

0.195*

0.165

0.212*

0.091

HDL1AC

0.101

0.064

0.110

0.072

HDL1BC

0.235*

0.166

0.250*

0.154

HDL2C

0.133

0.115

0.183

0.021

HDL3C

−0.095

−0.060

−0.186*

0.016

Hmed

0.209*

0.154

0.244*

0.107

V+LDLC

0.278*

0.177

0.093

0.409**

VLDL1C

0.179

0.077

0.081

0.285*

VLDL2C

0.385**

0.261*

0.354**

0.322**

LDL1C

0.373**

0.242*

0.287*

0.381**

LDL2C

0.255*

0.148

0.112

0.366**

LDL3C

0.031

0.014

−0.100

0.164

LDL4C

−0.087

−0.054

−0.172

0.014

Bmed

0.250*

0.157

0.246*

0.205*

APOAI

0.028

0.031

0.065

−0.037

APOB

−0.020

−0.078

−0.052

0.104

APOE

0.029

0.075

0.061

−0.084

TG

−0.091

−0.114

−0.115

0.017

CRP

0.162

0.109

0.162

0.121

IL8

−0.100

−0.136

0.019

−0.109

LpPLA2

0.168

0.170

0.004

0.227*

OxLDL

0.226*

0.159

0.029

0.364**

PON1-para

0.077

0.053

0.029

0.104

PON1-aryl

0.025

0.030

−0.028

0.057

TAS

−0.022

0.038

0.007

−0.106

VWF

−0.053

−0.063

−0.001

−0.055

Author Manuscript

B. After seven weeks on the HCHF atherogenic diet.

Trait

PC1

Aortic Arch

Thoracic
Aorta

Common Iliac

TSC

0.499**

0.425**

0.300**

0.440**

HDLC

0.098

0.142

0.036

0.046

HDL1AC

0.121

−0.038

0.286

0.050
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B. After seven weeks on the HCHF atherogenic diet.
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Trait

PC1

Aortic Arch

Thoracic
Aorta

Common Iliac

HDL1BC

0.353

0.368**

0.263

0.186*

HDL2C

−0.043

0.078

−0.168

−0.024

HDL3C

−0.189*

−0.250*

−0.062

−0.120

Hmed

0.252*

0.242*

0.203

0.139

V+LDLC

0.481**

0.414**

0.319**

0.386**

VLDL1C

0.365**

0.242*

0.166

0.448**

VLDL2C

0.365**

0.236*

0.168

0.453**

LDL1C

0.491**

0.445**

0.267

0.428**

LDL2C

0.009

0.136

0.106

−0.231*

LDL3C

−0.125

−0.007

−0.001

−0.292*

LDL4C

0.058

0.113

0.168

−0.149

Bmed

0.318**

0.196*

0.178

0.373**

APOAI

0.077

0.137

0.108

−0.072

APOB

0.378

0.321**

0.267

0.292*

APOE

0.170

0.052

0.075

0.277*

TG

−0.300**

−0.278*

−0.185

−0.234*

CRP

0.103

0.152

0.022

0.059

IL8

−0.178

−0.263*

−0.131

−0.011

LpPLA2

0.250*

0.190*

0.107

0.287*

OxLDL

0.068

0.130

−0.138

0.158

PON1-para

−0.135

−0.077

0.127

−0.114

PON1-aryl

−0.119

−0.077

−0.088

−0.116

TAS

−0.165

−0.079

−0.226

−0.088

VWF

−0.171

−0.207*

−0.051

−0.099

C. After 104 weeks on the HCHF atherogenic diet.
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Trait

PC1

Aortic Arch

Thoracic Aorta

Common Iliac

TSC

0.345**

0.327**

0.108

0.379**

HDLC

0.001

−0.037

−0.050

0.088

HDL1AC

0.098

0.004

0.154

0.094

HDL1BC

0.086

0.047

0.096

0.070

HDL2C

0.022

0.001

−0.072

0.117

HDL3C

−0.177

−0.154

−0.193*

−0.087

Hmed

0.114

0.054

0.181

0.055

V+LDLC

0.410**

0.403**

0.200*

0.372**

VLDL1C

0.249*

0.245*

0.019

0.315**

VLDL2C

0.383**

0.347**

0.113

0.443**
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C. After 104 weeks on the HCHF atherogenic diet.
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Trait

PC1

Aortic Arch

Thoracic Aorta

Common Iliac

LDL1C

0.451**

0.440**

0.241*

0.391**

LDL2C

0.053

0.029

0.113

−0.003

LDL3C

−0.279*

−0.244*

−0.014

−0.393**

LDL4C

−0.069

−0.039

0.074

−0.189*

Bmed

0.363**

0.368**

0.063

0.413**

APOAI

−0.037

−0.038

−0.088

0.030

APOB

0.280*

0.300**

0.131

0.232*

APOE

0.112

0.113

0.032

0.117

TG

−0.168

−0.184

−0.065

−0.146

CRP

0.136

0.065

0.178

0.099

IL8

0.112

0.045

0.164

0.076

LpPLA2

0.275*

0.27*2

0.140

0.241*

OxLDL

0.187*

0.212*

0.070

0.157

PON1-para

0.007

0.016

0.001

0.001

PON1-aryl

0.046

0.048

0.031

0.030

TAS

0.086

0.037

−0.130

0.281*

VWF

−0.031

−0.049

−0.082

0.065

1

Pearson product-moment correlations

*

At α = 0.05 with nominally significant P = 0.05, |r| = 0.186 (2-tailed test).

**

At α = 0.05 with Bonferroni corrected P = 0.00185, |r| = 0.292 (2-tailed test).
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25.8
102.7
51.1
51.6
68.7
86.5
53.2
33.4
86.2
5.1
13.8
5.5

Brachial systolic pressure

Brachial diastolic pressure

Brachial pulse pressure

Brachial mean pressure

Aortic systolic pressure

Aortic diastolic pressure

Aortic pulse pressure

Aortic heart rate

Augmentation pressure

Augmentation index (%)

Pulse wave velocity

1.9

14.3

5.2

15.9

9.3

11.4

15.0

13.2

13.8

11.2

16.8

6.2

1.8

sd

5.1

14.0

5.0

83.0

32.0

54.0

86.0

69.0

50.0

52.0

103.0

27.4

11.3

med

6.8

21.9

9.1

86.9

38.0

54.3

92.3

72.4

55.6

51.9

107.9

23.9

11.6

mean

3.2

12.7

7.6

17.0

11.9

15.1

16.2

15.4

14.9

14.7

18.0

6.6

1.7

sd

6.1

21.5

7.0

84.5

35.0

49.5

94.5

69.0

53.0

48.0

109.5

23.3

11.1

med

Challenge (n = 50)
HCHF Diet

↑*

↑**

↑**

ns

↑*

ns

↑*

ns

ns

ns

ns

ns

ns

Δ
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P = 0.01; ns, no nominally significant difference – i.e., P ≥ 0.05.

P = 0.05; and

**

*

Mean, arithmetic mean; sd, standard deviation; med, median; Δ, Direction of mean differences between two groups of baboons (i.e., controls fed only the LCLF diet and challenge animals fed the HCHF
challenge diet for two years);

All blood pressures: mm Hg; heart rate: beats per minute; augmentation pressure: difference between peak aortic pressure at second and first systolic peak; augmentation index: augmentation pressure/pulse
pressure × 100; Pulse wave velocity: m/s).

11.7

Weight (kg)

mean

Age (years)

Traits

Controls (n = 41)
LCLF Diet

Arterial compliance examined by pulse wave analysis using applanation tonometry in controls fed a basal LCLF diet and in challenge animals fed a
HCHF diet for two years.
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Author Manuscript
−0.082
0.195
0.020

0.448**
0.331*
0.366**

0.163
0.473**
0.347*
0.424**
0.285*
0.226
0.184

0.388**
0.252*
0.259*

0.264*
0.429**
0.237*
0.165
0.224
0.156
0.365**

Diastolic Pressure

Pulse Pressure

Mean Pressure

Systolic Pressure

Diastolic Pressure

Pulse Pressure

Heart Rate

Augmentation Pressure

Augmentation index (%)

Pulse wave velocity

0.238*

0.005

0.390**

0.396**

Aortic

0.431**

0.138

0.394**

0.070

0.169

−0.079

0.153

0.211

0.283*

0.269*

0.574**

0.426**

0.590**

0.268*

0.580**

0.341*

Aortic
Arch

0.192

−0.091

0.309*
0.367*

−0.087

0.078

0.010

0.320*

0.378**

0.344*

−0.025

0.316*

0.287*

Common
Iliac

0.282*

0.121

0.080

0.082

0.282*

0.149

−0.036

0.090

0.144

Thoracic
Aorta

Lesion extent
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**

Bonferroni corrected P = 0.0064 and |r| = 0.35 (1-tailed tests).

At α = 0.05, * nominal P = 0.05 and |r| = 0.235; at α = 0.05,

Partial correlations between sex- and age-adjusted (when appropriate) residuals, conditional on body weight. Correlations with plaque measures are Spearman rank-order correlations. Correlations with
lesion extent measures are Pearson product-moment correlations.

1

PC1

0.301*

Brachial

Total
number

Systolic Pressure

Sum of
areas

Plaque

Correlations1 with plaque and lesions.

Arterial compliance-related measures from pulse wave analysis in 50 pedigreed baboons following a two-year HCHF atherogenic diet challenge:
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